Dermatological Disorders – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Dermatological Disorders – Drugs In Development, 2024 report and make more profitable business decisions.
Dermatological disorders are diseases or conditions that affect the skin, hair, or nails. They can have various causes, symptoms, and treatments. Some of the most common dermatological disorders are acne, eczema, psoriasis, rosacea, and warts. Dermatologists are doctors who specialize in diagnosing and treating these disorders. Dermatological disorders can affect the appearance, function, and quality of life of the patients. Some of them can also increase the risk of skin cancer or other complications.
The Dermatological Disorders drugs in development market research report provide comprehensive information on the therapeutics under development for Dermatological Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Dermatological Disorders and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Dermatological Disorders | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 35 molecules, with 32 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Dermatological Disorders therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Dermatological Disorders pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Dermatological Disorders treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Adora Life Science IncAldena Therapeutics Inc
Bodor Laboratories Inc
Caregen Co Ltd
Castle Creek Biosciences Inc
CSL Ltd
DermaXon LLC
DermBiont Inc
Dominion Minerals Ltd
EpiPharm AG
Eyesiu Medicines BV
Fresh Tracks Therapeutics Inc
Guardian Therapeutics Inc
HCW Biologics Inc
Helix BioMedix Inc
Lipidio Pharmaceuticals Inc
Maruho Co Ltd
Pfizer Inc
Polpharma Biologics SA
Profem GmbH
Ractigen Therapeutics Inc
Sisaf Ltd
Stemedica Cell Technologies Inc
SynDermix AG
Timber Pharmaceuticals Inc
Trophea AB
TWi Biotechnology Inc
Tyris Therapeutics SL
University of Wisconsin Madison
Vectans Pharma SAS
Vyome Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Dermatological Disorders reports